盧 孟良

Medicine & Life Sciences

1. Schizophrenia 100%
2. Olanzapine 74%
3. Antipsychotic Agents 58%
4. Clozapine 56%
5. Antidepressive Agents 36%
6. Cohort Studies 30%
7. Depression 30%
8. Bipolar Disorder 30%
9. Population 29%
10. desmethylolanzapine 28%
11. Metabolic Syndrome 27%
12. Major Depressive Disorder 25%
13. Psychotic Disorders 24%
14. Fluvoxamine 23%
15. Psychiatry 21%
16. Post-Traumatic Stress Disorders 20%
17. Earthquakes 20%
18. Metformin 18%
19. Adiponectin 17%
20. Weight Gain 17%
21. Unsaturated Fatty Acids 16%
22. Risperidone 15%
23. Meta-Analysis 15%
24. Psychopathology 15%
25. Ghrelin 14%
26. Therapeutics 14%
27. Quetiapine Fumarate 14%
28. Placebos 14%
29. Insulin Secretion 14%
30. Anxiety 14%
31. Lithium 12%
32. Firefighters 11%
33. National Health Programs 11%
34. Citalopram 11%
35. Serotonin Uptake Inhibitors 11%
36. Treatment-Resistant Depressive Disorder 11%
37. Protective Agents 10%
38. Genes 10%
39. Case-Control Studies 10%
40. Wounds and Injuries 10%
41. Depressive Disorder 10%
42. Omega-3 Fatty Acids 10%
43. Hepatocellular Carcinoma 10%
44. Pharmacokinetics 9%
45. Cognition 9%
46. Alleles 9%
47. Suicide 9%
48. Rescue Work 9%
49. Confidence Intervals 9%